Table of Content
- Introduction
- Definition of Asthma Treatment Market
- Scope of the Report
- Methodology
- Executive Summary
- Market Overview
- Market Definition and Segmentation
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Porter's Five Forces Analysis
- PESTEL Analysis
- Asthma Treatment Market, By Treatment:
- Long-Term Control Medications
- Quick-Relief Medications
- Asthma Treatment Market, By Route of Administration:
- Injectable
- Oral
- Inhaled
- Asthma Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Asthma Treatment Market, By Geography
- North America
- United States
- Canada
- Europe
- United Kingdom
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of Middle East & Africa
- North America
- Competitive Landscape
- Company Profiles
- AstraZeneca
- Company Overview
- Product Portfolio and Description
- Key Highlights
- Financial Overview
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Mylan N.V.
- Boehringer Ingelheim International GmbH
- Regeneron
- Sanofi
- Genentech, Inc. (F. Hoffmann-La Roche Ltd)
- Novartis AG
- Sumitomo Dainippon Pharma Co., Ltd.
- List Exhastive
- AstraZeneca
- Conclusion and Future Outlook
- Appendix
- Research Methodology
- About the Pharmanucleus
- Disclaimer